These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 22828589
1. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults. Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF. Vaccine; 2012 Sep 07; 30(41):5973-7. PubMed ID: 22828589 [Abstract] [Full Text] [Related]
2. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. Potsch DV, Oliveira ML, Ginuíno C, Miguel JC, Oliveira SA, Silva EF, Moreira RB, Cruz GV, Oliveira AL, Camacho LA, Barroso PF. Vaccine; 2010 Feb 10; 28(6):1447-50. PubMed ID: 19995540 [Abstract] [Full Text] [Related]
3. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy. Lao-Araya M, Puthanakit T, Aurpibul L, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Vaccine; 2011 May 23; 29(23):3977-81. PubMed ID: 21473954 [Abstract] [Full Text] [Related]
4. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Bailey CL, Smith V, Sands M. Int J Infect Dis; 2008 Nov 23; 12(6):e77-83. PubMed ID: 18723381 [Abstract] [Full Text] [Related]
10. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial. Chaiwarith R, Praparattanapan J, Kotarathititum W, Wipasa J, Chaiklang K, Supparatpinyo K. AIDS Res Ther; 2019 Nov 11; 16(1):33. PubMed ID: 31711528 [Abstract] [Full Text] [Related]
11. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine. Zhang W, Han L, Lin C, Wang H, Pang X, Li L, Gao P, Lin H, Gong X, Tang Y, Ma J, Zhang H, Wang C, Yang P, Li H, Sun M, He X. Vaccine; 2011 Aug 26; 29(37):6276-82. PubMed ID: 21722684 [Abstract] [Full Text] [Related]
13. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda. Mutwa PR, Boer KR, Rusine JB, Muganga N, Tuyishimire D, Reiss P, Lange JM, Geelen SP. Pediatr Infect Dis J; 2013 Mar 26; 32(3):246-51. PubMed ID: 22976050 [Abstract] [Full Text] [Related]
14. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Cruciani M, Mengoli C, Serpelloni G, Lanza A, Gomma M, Nardi S, Rimondo C, Bricolo F, Consolaro S, Trevisan M, Bosco O. Vaccine; 2009 Jan 01; 27(1):17-22. PubMed ID: 18984022 [Abstract] [Full Text] [Related]
16. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Vaccine; 2012 Jun 08; 30(27):4034-9. PubMed ID: 22531558 [Abstract] [Full Text] [Related]
17. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels. O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, Bavaro MF, O'Connell RJ, Agan BK, Landrum ML. HIV Med; 2015 Mar 08; 16(3):161-7. PubMed ID: 25586899 [Abstract] [Full Text] [Related]
18. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, Wendling MJ, Vetter D, Nicolle M, Kempf-Durepaire G, Lang JM. Vaccine; 2000 Jan 18; 18(13):1161-5. PubMed ID: 10649616 [Abstract] [Full Text] [Related]
19. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C. HIV Med; 2008 Aug 18; 9(7):519-25. PubMed ID: 18554311 [Abstract] [Full Text] [Related]
20. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. Piroth L, Launay O, Michel ML, Bourredjem A, Miailhes P, Ajana F, Chirouze C, Zucman D, Wendling MJ, Nazzal D, Carrat F, Rey D, Binquet C, ANRS HB EP03 CISOVAC Study Group. J Infect Dis; 2016 Jun 01; 213(11):1735-42. PubMed ID: 26768256 [Abstract] [Full Text] [Related] Page: [Next] [New Search]